The potential indirect effect of conjugate pneumococcal vaccines.
about
Pneumococcal vaccine for preventing Streptococcus pneumoniae infection in HIV-infected individualsPneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and pneumonia with consolidation on x-ray in children under two years of ageEquity and child-survival strategiesNasopharyngeal carriage of individual Streptococcus pneumoniae serotypes during pediatric radiologically confirmed community acquired pneumonia following PCV7 introduction in Switzerland.Impact of capsular switch on invasive pneumococcal disease incidence in a vaccinated population.The dynamics of nasopharyngeal streptococcus pneumoniae carriage among rural Gambian mother-infant pairsPneumococcal Vaccination Strategies. An Update and Perspective.CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization.Impact of routine PCV7 (Prevenar) vaccination of infants on the clinical and economic burden of pneumococcal disease in Malaysia.Primary vaccination with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in infants in Mali and Nigeria: a randomized controlled trial.Short- and long-term effects of pneumococcal conjugate vaccination of children on penicillin resistanceAge-specific immunoglobulin g (IgG) and IgA to pneumococcal protein antigens in a population in coastal kenya.Potential impact of conjugate vaccine on the incidence of invasive pneumococcal disease among children in ScotlandPneumococcal conjugate vaccination in Canadian infants and children younger than five years of age: Recommendations and expected benefits.Safety and immunogenicity of neonatal pneumococcal conjugate vaccination in Papua New Guinean children: a randomised controlled trialInferior quantitative and qualitative immune responses to pneumococcal conjugate vaccine in infants with nasopharyngeal colonization by Streptococcus pneumoniae during the primary series of immunization.Impact on respiratory tract infections of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months of age.An outbreak of pneumococcal meningitis among older children (≥5 years) and adults after the implementation of an infant vaccination programme with the 13-valent pneumococcal conjugate vaccine in Ghana.Prospects for a vaccine against otitis media.Effect of swab composition and use of swabs versus swab-containing skim milk-tryptone-glucose-glycerol (STGG) on culture- or PCR-based detection of Streptococcus pneumoniae in simulated and clinical respiratory specimens in STGG transport medium.Population-based impact of routine infant immunization with pneumococcal conjugate vaccine in the USA.Pneumococcal serotype distribution in adults with invasive disease and in carrier children in Italy: Should we expect herd protection of adults through infants' vaccination?Pneumococcal conjugated vaccines: impact of PCV-7 and new achievements in the postvaccine era.Impact of infant immunization programs with pneumococcal conjugate vaccine in Europe.Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) [Prevenar 13(®)]: profile report.Serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Bulgaria before the introduction of pneumococcal conjugate vaccine.The Pertussis resurgence: putting together the pieces of the puzzle.Trends in incidence of pneumococcal disease before introduction of conjugate vaccine: South West England, 1996-2005.The relationship between mucosal immunity, nasopharyngeal carriage, asymptomatic transmission and the resurgence of Bordetella pertussis.Pneumococcal conjugated vaccine: PHiD-CV.Antimicrobial susceptibility of invasive and lower respiratory tract isolates of Streptococcus pneumoniae, 1998 to 2007.Incidence and mortality of acquired brain injury in young Danish adults between 1994 and 2013: a nationwide study.WciG O-Acetyltransferase Functionality Differentiates Pneumococcal Serotypes 35C and 42.Incidence of invasive pneumococcal disease in the Czech Republic and serotype coverage by vaccines, 1997-2006.Evaluation of different infant vaccination schedules incorporating pneumococcal vaccination (The Vietnam Pneumococcal Project): protocol of a randomised controlled trial.Pneumococcal carriage in households in Karonga District, Malawi, before and after introduction of 13-valent pneumococcal conjugate vaccination
P2860
Q24186767-FDBFD51F-242A-4140-975C-00BC9EF83C54Q24245934-17D0A488-C97C-4DB9-AC41-A6B0F5DB294BQ24648803-B5AD4A90-577C-4E88-93C6-A5DDCCD32A5AQ31125433-BEBB6C24-2F3D-49E8-A52A-3E65F4AAB98CQ33370549-33CBD819-A3FD-4375-B966-34808D753B91Q33625426-BA2B8646-3CA7-4C91-90A3-60651DB6EC3DQ33772409-8B54CD22-1F8A-4B78-BFA2-169A4BDA9724Q33935327-33A7992D-59F4-464B-AE8B-AF6AABE03607Q34026849-436E4427-2EEF-41F0-9353-9639134BBDADQ34082225-D644118D-22AE-4D66-8B5C-48F6B1758333Q34140625-1BA81095-3ED3-4ED6-AE6D-CDC32A5F95F8Q34145758-EE96D2C3-50B7-49A3-90D5-E1440742BE52Q34569142-9F38A0BA-5A34-4A1A-87C0-7B63C6838FEAQ34590621-3062940C-7F0C-4CD0-A6B1-C8F5927FA670Q34602513-EF9A30AB-E0F8-4647-A28A-33A0905F7551Q35199219-E980C24C-6ECF-456E-97DA-7379A5FBD759Q35649092-4E810C55-1F79-42F5-91CF-1DA3D1719758Q36166629-9C47CA69-29F7-455B-A778-480DEB77BD34Q36600356-2D2C27BC-A6B4-4F16-9285-E6D3EECBE6B5Q36845354-570ECE98-6FB5-448D-BD17-F6BE461C6B1EQ37077655-81F96A6C-4661-4CA2-A027-3FEBEA79F9E6Q37309269-F1FA4260-9BAE-4171-B733-B2F231825447Q37316015-7EAF33EF-8452-4A0C-8F18-DE7D5C9770D0Q37608307-C709BB61-8C7E-4415-83EF-29088EE92307Q37965672-B3184F93-1174-46E3-9128-C9BE389012BCQ39623042-9C960154-A7F3-4CAA-8B62-204426E60FA2Q40061323-B745C14E-62C2-4D0A-9269-2DEFD0B863B2Q40160418-7B7B5208-471F-4179-948F-12ED60C75849Q41588991-4936839F-1624-42EB-B8BE-062E3330CC5BQ42638322-D85A0AFA-A3B8-449C-B388-35D02758BE56Q42789542-E33C8E80-CEEF-4B05-A4FF-B686D92F191FQ48093530-30A52EBE-B2FC-4055-A171-DCFAFE5D764BQ48207606-38EBC282-C684-4A2F-A57F-AA5ED726D62CQ51122671-12D55B58-CE97-4DC3-9A05-9013FF3A79CFQ55313306-87B656F6-EF76-4706-96F9-1005B9EEC053Q57808996-DC96DAB6-B683-482E-AA2A-205A2A9DC149
P2860
The potential indirect effect of conjugate pneumococcal vaccines.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The potential indirect effect of conjugate pneumococcal vaccines.
@ast
The potential indirect effect of conjugate pneumococcal vaccines.
@en
type
label
The potential indirect effect of conjugate pneumococcal vaccines.
@ast
The potential indirect effect of conjugate pneumococcal vaccines.
@en
prefLabel
The potential indirect effect of conjugate pneumococcal vaccines.
@ast
The potential indirect effect of conjugate pneumococcal vaccines.
@en
P1433
P1476
The potential indirect effect of conjugate pneumococcal vaccines.
@en
P2093
P304
P356
10.1016/S0264-410X(02)00807-1
P407
P50
P577
2003-05-01T00:00:00Z